A carregar...
Buformin suppresses osteosarcoma via targeting AMPK signaling pathway
BACKGROUND: Buformin has been reported to be a powerful anticancer drug by activating the AMPK signal. Herein, we aimed to investigate the effects of buformin on osteosarcoma. MATERIAL AND METHODS: Cellular proliferative abilities were determined by cell counting kit-8 and colony formation assays. C...
Na minha lista:
| Publicado no: | Open Life Sci |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
De Gruyter
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7874575/ https://ncbi.nlm.nih.gov/pubmed/33817229 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/biol-2020-0041 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|